Efficacy of Enteral Iron Supplementation in Critical Illness

Completed · Phase 2 · Has a placebo group

Conditions studied: Anemic, Critically Ill Patients

In brief

The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are hospitalized in the intensive care unit. This study will also address any relationship between enteral iron supplementation and risk of infection.

Key facts

Study ID

NCT00450177

Run by

Weill Medical College of Cornell University

People needed

200

Starts

2006-01-01

Expected to finish

2008-01-01

Last updated by the study team

2019-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• Anemia (Hemoglobin < 13.0 g/dL)
• ≤ 72 hours from hospital admission
• Current tolerance of enteral medications
• Expected ICU LOS > 5 days

You may not qualify if…

• Active bleeding
• Chronic inflammatory disease
• End-stage renal disease
• Hematologic disorders
• Macrocytic anemia
• Current use of erythropoietin
• Pregnancy
• Prohibition of RBC transfusions
• Moribund state in which death is imminent
• Enrollment in another clinical trial

Where it is running

• Weill Medical College of Cornell University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.